LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 1235 | 594 | 4126 | 0.1440 | -0.3435 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 1235 | 2953 | 3974 | 0.7431 | 0.6769 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 1235 | 2855 | 4070 | 0.7014 | 0.6274 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 1235 | 2684 | 4126 | 0.6505 | 0.5620 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 1235 | 2862 | 3974 | 0.7202 | 0.6461 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 1235 | 2754 | 4070 | 0.6766 | 0.5937 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 1235 | 3056 | 4126 | 0.7406 | 0.6830 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 1235 | 3471 | 3974 | 0.8734 | 0.8457 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 1235 | 3213 | 4070 | 0.7894 | 0.7431 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 1235 | 3221 | 4126 | 0.7806 | 0.7346 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 1235 | 3136 | 3974 | 0.7891 | 0.7378 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 1235 | 2892 | 4070 | 0.7105 | 0.6396 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 1235 | 3532 | 4126 | 0.8560 | 0.8290 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 1235 | 2215 | 3974 | 0.5574 | 0.4139 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 1235 | 2392 | 4070 | 0.5877 | 0.4683 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 1235 | 2244 | 4126 | 0.5438 | 0.4092 |
MCF7 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 1235 | 618 | 3974 | 0.1555 | -0.3370 |
MCF7 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 1235 | 738 | 4070 | 0.1813 | -0.2588 |
MCF7 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 1235 | 637 | 4126 | 0.1544 | -0.3166 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1235 | 1966 | 3974 | 0.4947 | 0.3174 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1235 | 1909 | 4070 | 0.4690 | 0.2879 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1235 | 1984 | 4126 | 0.4808 | 0.3130 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1235 | 1715 | 3974 | 0.4315 | 0.2148 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1235 | 1859 | 4070 | 0.4567 | 0.2682 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1235 | 1781 | 4126 | 0.4316 | 0.2340 |